Prasco Laboratories Jan. 12 announced it has entered into an agreement with Shire to distribute an authorized generic version of Carbatrol (carbamazepine) extended-release capsules in 100 mg, 200 mg, and 300 mg strengths in the United States.
An authorized generic drug is a branded prescription drug produced by the brand-name manufacturer and repackaged as a generic. Financial terms of the agreement were not disclosed.
Shire’s Carbatrol is used to treat certain types of seizures and certain types of nerve pain, Mason, Ohio-based Prasco said.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.